GS-9451 placebo

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Hepatitis C, Chronic

Phase 2

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

CompletedNCT01271790

Gilead SciencesHepatitis C, Chronic

Start: 2010-10-31End: 2013-09-30Updated: 2014-02-06

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

CompletedNCT01356160

Gilead SciencesHepatitis C, Chronic

Start: 2011-07-31End: 2013-06-30Updated: 2014-02-03